Trial intelligence / Profile preview

OT-551 in Geographic Atrophy

NCT00485394Phase 2Unknown

Sponsor
Othera Pharmaceuticals, Inc.
Start
Jun 2007
Primary completion
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of OT-551 in geographic atrophy (GA), sponsored by Othera Pharmaceuticals, Inc.. Status: unknown.

02

Drugs

OT-551
03

Conditions

geographic atrophy (GA)

Beyond the preview

Go deeper on NCT00485394.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00485394.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call